Third generation fluoroquinolones lomefloxacin fluoroquinolones. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms25

Gram-Negative Bacteria Streptococcus pneumoniae Neisseria gonorrhoeae Staphylococcus aureus Bacteria Mycoplasma hominis Escherichia coli Clostridium difficile Mycobacterium fortuitum Pseudomonas aeruginosa Gram-Positive Bacteria Salmonella typhi Laurus Bartonella bacilliformis Mycobacterium tuberculosis Gram-Positive Cocci Campylobacter Moraxella (Branhamella) catarrhalis Klebsiella pneumoniae Salmonella paratyphi A Salmonella enterica Bacteria, Anaerobic Enterobacteriaceae Bacteroides fragilis Campylobacter jejuni

Diseases28

Dermatitis, Phototoxic Ureterolithiasis Thromboembolism Gram-Negative Bacterial Infections Urinary Tract Infections Pneumococcal Infections Bacterial Infections Typhoid Fever Hepatitis C Community-Acquired Infections Escherichia coli Infections Enterocolitis, Pseudomembranous Paratyphoid Fever Cross Infection Gram-Positive Bacterial Infections Otitis Externa Gonorrhea Respiratory Tract Infections Campylobacter Infections Extensively Drug-Resistant Tuberculosis Clostridium Infections Pseudomonas Infections Eye Infections, Bacterial Tuberculosis, Multidrug-Resistant Staphylococcal Infections Dermatitis, Photoallergic Salmonella Infections Klebsiella Infections

Chemicals and Drugs54

Fluoroquinolones Anti-Infective Agents Quinolones 4-Quinolones Ciprofloxacin Ofloxacin Norfloxacin Contraceptives, Oral, Synthetic Anti-Bacterial Agents Enoxacin DNA Gyrase Aza Compounds Naphthyridines Levofloxacin DNA Topoisomerase IV Desogestrel Fleroxacin Quinolines Norpregnenes Pefloxacin Contraceptives, Oral, Combined Cephalosporins DNA Topoisomerases, Type II Contraceptives, Oral beta-Lactamases Oxazines Nalidixic Acid Topoisomerase II Inhibitors Hepatitis C Antibodies Aromatase Inhibitors Theophylline Macrolides Cefuroxime beta-Lactams Photosensitizing Agents Nitrofurantoin DNA, Bacterial Aminoglycosides Capreomycin Antitubercular Agents Bacterial Proteins Anti-Infective Agents, Urinary Glucuronates Trimethoprim-Sulfamethoxazole Combination Tetracyclines Carbapenems Ethambutol Dioxolanes Lactams Erythromycin Ketolides Membrane Transport Proteins Minocycline DNA Topoisomerases

Analytical, Diagnostic and Therapeutic Techniques and Equipment19

Microbial Sensitivity Tests Polarography Risk Factors Treatment Outcome Pedigree Administration, Oral Prevalence Case-Control Studies Chromatography, High Pressure Liquid Cohort Studies Prospective Studies Retrospective Studies Chromatography, Supercritical Fluid Electrophoresis, Gel, Pulsed-Field Serum Bactericidal Test Ribotyping Area Under Curve Colony Count, Microbial Sequence Analysis, DNA

Phenomena and Processes13

Drug Resistance, Bacterial Drug Resistance, Microbial Drug Resistance, Multiple, Bacterial Half-Life Drug Interactions Mutation Time Factors Drug Resistance, Multiple Ultraviolet Rays beta-Lactam Resistance Area Under Curve Genes, Bacterial Cephalosporin Resistance

Information Science2

Prevalence Molecular Sequence Data

Named Groups1

Infant, Newborn

Health Care11

Risk Factors Treatment Outcome Drug Utilization Ultraviolet Rays Prevalence Case-Control Studies Cohort Studies Prospective Studies Retrospective Studies Area Under Curve Hospitals

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Fluoroquinolones Anti-Infective Agents Quinolones 4-Quinolones Ciprofloxacin Ofloxacin Dermatitis, Phototoxic Norfloxacin Contraceptives, Oral, Synthetic Microbial Sensitivity Tests Anti-Bacterial Agents Enoxacin DNA Gyrase Aza Compounds Naphthyridines Levofloxacin Drug Resistance, Bacterial DNA Topoisomerase IV Desogestrel Fleroxacin Quinolines Norpregnenes Pefloxacin Contraceptives, Oral, Combined Drug Resistance, Microbial Ureterolithiasis Drug Resistance, Multiple, Bacterial Cephalosporins DNA Topoisomerases, Type II Contraceptives, Oral Gram-Negative Bacteria Thromboembolism Streptococcus pneumoniae Polarography beta-Lactamases Oxazines Neisseria gonorrhoeae Nalidixic Acid Topoisomerase II Inhibitors Half-Life Gram-Negative Bacterial Infections Drug Interactions Urinary Tract Infections Hepatitis C Antibodies Aromatase Inhibitors Theophylline Macrolides Mutation Staphylococcus aureus Cefuroxime Bacteria Risk Factors Mycoplasma hominis Escherichia coli beta-Lactams Clostridium difficile Pneumococcal Infections Bacterial Infections Typhoid Fever Mycobacterium fortuitum Photosensitizing Agents Hepatitis C Nitrofurantoin DNA, Bacterial Aminoglycosides Pseudomonas aeruginosa Time Factors Gram-Positive Bacteria Treatment Outcome Capreomycin Antitubercular Agents Community-Acquired Infections Drug Resistance, Multiple Bacterial Proteins Drug Utilization Ultraviolet Rays Pedigree Escherichia coli Infections Administration, Oral Prevalence Enterocolitis, Pseudomembranous Case-Control Studies Chromatography, High Pressure Liquid Paratyphoid Fever Cohort Studies Cross Infection Anti-Infective Agents, Urinary Glucuronates Salmonella typhi Laurus Prospective Studies Bartonella bacilliformis Mycobacterium tuberculosis Gram-Positive Cocci Retrospective Studies Campylobacter Gram-Positive Bacterial Infections Moraxella (Branhamella) catarrhalis Otitis Externa Gonorrhea

No FAQ available that match "third generation fluoroquinolones lomefloxacin fluoroquinolones"